AbbVie Highlights Robust Gastroenterology Portfolio with New Analyses and Data in Inflammatory Bowel Diseases at the 18th Congress of European Crohn's and Colitis Organisation (ECCO)PRNewsWire • 02/27/23
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Crohn's DiseasePRNewsWire • 02/27/23
7 ‘Strong Buy' 2023 Dividend Aristocrats to Buy Now and Hold Forever in Your IRA24/7 Wall Street • 02/24/23
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet NeedPRNewsWire • 02/23/23
Want to Get to $1 Million by Retirement? Here's How Much You Should Invest Today.The Motley Fool • 02/22/23